Study of a medicine to treat high potassium in children
Part of Hormones & metabolism clinical trials.
This trial tests how safe and effective SZC is for children with high potassium levels (hyperkalaemia) over the short term, and possibly long term. It aims to help lower potassium safely and see whether it works well in different pediatric age groups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be from birth up to under 18 years old during the study
- Your child must have high potassium that meets the trial’s lab and urine/blood criteria
- At screening, an ECG (heart tracing) must meet age-specific limits for “QTc” timing
- Your child must be able to have repeated blood draws, or blood can be taken via an IV/vein line
- If your child can become pregnant: they must have a negative pregnancy test and use two reliable birth-control methods
- They must not have certain causes of high potassium (for example, dehydration or specific medication causes) and must not need immediate heart treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses AI to look at your ECG and decide the best time to give treatment for high potassium (levels over 5.5). It aims to find the most effective timing to lower potassium safely in the emergency room.
This trial tests if a medication called patiromer, combined with a low-potassium diet, can help manage potassium levels in people on chronic dialysis. The goal is to improve quality of life by allowing a more flexible diet.
This trial tests whether managing potassium levels better can protect the heart in people on long-term dialysis. It aims to show how reducing ups and downs in potassium might lower heart risks.
This trial tests a medication (SZC) that helps lower high potassium levels, so you can keep taking important heart and kidney drugs (RAASi/MRA). It is for people with heart failure and chronic kidney disease who have high potassium.
This trial tests a new drug called WS016 to lower high potassium levels in adults. High potassium can be dangerous for your heart, and this study aims to find out if WS016 is safe and effective.
This study looks at how common high potassium levels are in people with chronic kidney disease who are not on dialysis. It may help find who is at risk and how to prevent it.
Hear when a new Hyperkalaemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.